Ulvera AI Welcomes Domenic Serafino as CEO
Ulvera AI, an innovative company in the non-invasive body contouring sector, has appointed Domenic Serafino as its new Chief Executive Officer and Co-Founder. The announcement comes amid the company's efforts to revolutionize the aesthetics medical technology field. With over 30 years of leadership experience in medical aesthetics, Serafino is well-positioned to steer Ulvera AI's strategic direction.
Prior to joining Ulvera AI, Serafino co-founded Venus Concept Inc. in 2010, where he served as CEO until 2022, successfully scaling the company to over $120 million in annual revenues. Additionally, he was a key player at Syneron Medical Corp., helping to launch the company and leading its North American operations before steering it to a successful IPO in 2004, achieving a remarkable market cap growth of $1.4 billion.
Expressing his enthusiasm for the new role, Serafino stated, "I am honored to be part of Ulvera AI and lead its innovative journey in medical aesthetics. Our team's commitment to developing groundbreaking technologies is inspiring, and I am excited about the potential impact of our advancements in non-invasive body contouring."
Ulvera AI specializes in advanced body contouring technology, utilizing a unique approach that integrates ultrasound and electric muscle stimulation (EMS). This multi-layered treatment enables personalized patient experiences, significantly enhancing clinical outcomes. Studies have shown a fat layer reduction of between 18% and 27%, averaging at 23%, demonstrating the effectiveness of this cutting-edge system.
Dr. Grant Stevens, who collaborates with Serafino, expressed great anticipation for their collaboration, stating, "With this innovative technology, we can target stubborn fat areas and achieve skin tightening effectively and affordably. It's a significant leap forward in patient comfort and treatment precision."
Dr. Ines Verner, Co-Founder and President of Ulvera AI, also acknowledged the importance of Serafino's appointment: "Bringing Dom on board is a transformative step for Ulvera AI. His visionary leadership aligns perfectly with our ambitious goals, and we are eager to leverage his insights to drive our innovative vision forward."
Domenic Serafino's leadership is expected to significantly enhance Ulvera AI's prospects in the non-invasive aesthetics medical device market, ensuring the company remains at the forefront of innovation and excellence. As Ulvera AI continues to develop personalized treatment solutions, its commitment to technological advancement and patient satisfaction will likely solidify its leadership in the industry.
About Ulvera AI
Founded in Tel Aviv, Ulvera AI is an Israeli startup dedicated to pioneering technology in the non-invasive body contouring arena. The company envisions personalized treatment pathways for each patient, offering innovative solutions in the aesthetic medical industry.
For media inquiries, reach out to:
Dr. Ines Verner
Co-Founder, Ulvera AI
Email: [email protected]
Phone: +972-52-6544600